Replies to post #378290 on NorthWest Biotherapeutics Inc (NWBO)

[Nick119]

What I'd love an answer to, which you will never answer in a straight forward manner is, why would any investor care about this information when the vast majority of investors realize that this is the expectation of a company in the final stages of TLD results for a 15-year trial, seeking regulatory approval across 4 different RA bodies. Secondly, what incentive would any one on this board have to be cherry picking out random details to build a false narrative ??? OH that's right, a paid FUDster.

What you should really be asking yourself is why would the (unblinded) NWBO be pursuing MHRA certification on a facility to produce a failed treatment?.. and weigh the odds of the answers we all know is correct here. This is HILARIOUS! GLTU - LY EX!